Research into the genetic origins of schizophrenia and bipolar disorder suggests that, while distinct, the two mental illnesses are more alike than different.
Mixed results in tests of medications for the treatment of ADHD have led to interest in neurofeedback as a possible alternative, but research into its effectiveness has not been conclusive so far.
In experiments on mice, suppressing a chemical linked to stress and appetite prevented the formation of abdominal fat cells, which could lead to new possibilities for weight loss drugs.
The World Health Organization found that many people worldwide are not receiving needed mental health care and services.
A long-term trial of schizophrenia drugs has found that newer medications are not any more effective than a first-generation drug, but questions have been raised about the parameters of the study.
Most instances of infertility have a physiological cause, but the emotional and mental toll is significant, and fertility treatments can add to the stress.
Mild cognitive impairment is considered to be the state between normal mental function and dementia. Researchers are seeking a way to diagnose the condition sooner, so that medication can be used to treat or at least manage it, to keep it from worsening.
A study of antipsychotic medications in the treatment of young patients found more evidence that first- and second-generation drugs are not particularly effective.
The eating disorder bulimia nervosa is characterized by a period of binge eating followed by a compensating action. Recommended treatment combines psychotherapy with nutritional counseling.
There was an error in the October 2009 article about premenstrual dysphoric disorder.